Kamiya Biomedical CO is categorized under Wholesale Chemicals in Seattle, WA and active since 1983.
Kamiya Biomedical CO was established in 1983, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Wholesale Chemicals business, which does work in the B2B market, and is classified as a Wholesale Chemicals, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Kohji Kamiya, Owner at the company’s single location by writing to 12779 Gateway Drive South, Seattle, Washington WA 98168 or by phoning (206) 575-8068. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kamiya Biomedical CO |
Contact Person: | Kohji Kamiya, Owner |
Address: | 12779 Gateway Drive South, Seattle, Washington 98168 |
Phone Number: | (206) 575-8068 |
Website Address: | kamiyabiomedical.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1983 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Chemicals |
SIC Code: | 5169 |
NAICS Code: | 3391120 |
Share This Business: |
Kamiya Biomedical CO was started in 1983 to provide professional Wholesale Chemicals under the SIC code 5169 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Kohji Kamiya, Owner for inquiries that concern Kamiya Biomedical CO by calling the company number (206) 575-8068, as your correspondence is most welcome. Additionally, the physical location of the single location of Kamiya Biomedical CO can be found at the coordinates 47.48879,-122.27304 as well as the street address 12779 Gateway Drive South in Seattle, Washington 98168.
For its online presence, you may visit Kamiya Biomedical CO’s website at kamiyabiomedical.com and engage with its social media outlets through on Twitter and on Facebook.